Charles Darwin once marveled at nature’s power to shape life through natural selection, dismissing humanity’s efforts at artificial selection as “feeble” by comparison. Today, that hierarchy is being upended in ways Darwin could never have imagined. Molecular biologist Adrian Woolfson argues in his new book On the Future of Species that humanity is poised to become the author of life itself, combining genome engineering with artificial intelligence to create organisms beyond 3.5 billion years of evolutionary constraints.
The New Architects of Life
Woolfson, co-founder of biotech company Genyro, describes scientists as “children learning to write” when it comes to synthetic biology. Yet their progress is accelerating. Researchers have already assembled synthetic genomes for viruses, bacteria, and yeast, and are expanding life’s chemical repertoire with new molecular building blocks. The UK’s Synthetic Human Genome project aims to create human cells with synthetic chromosomes for medical applications within a few years.
“With the assistance of AI, which has the potential to decode life’s generative grammar, and the agency of a chemical printing press capable of rendering the genome sequences of species as if they were books, our ability to manipulate life’s structures could become virtually limitless,” Woolfson writes. He envisions a future where we might grow houses rather than build them, wear clothing that converses with us, and integrate biological material into every aspect of daily life.
The Economic Engine Behind the Revolution
This biological revolution is being fueled by unprecedented investment in AI infrastructure. Nvidia, the world’s most valuable company with a $4.5 trillion market capitalization, has seen sales grow at 100% annually for three years, reaching $68 billion last quarter. Yet despite this explosive growth, investor enthusiasm appears to be cooling – Nvidia’s shares have been roughly flat over the past six months and now trade at the same forward price/earnings ratio as the S&P 500.
This market hesitation reflects deeper questions about AI’s economic impact. Howard Marks, co-founder of Oaktree Capital Management, notes that while “the technology itself is a very real thing, with the potential to vastly alter the business world,” there are legitimate concerns about circular revenue patterns and whether infrastructure spending will deliver expected returns. The distinction between speculative training capex and demand-driven inference capex becomes crucial for investors navigating this landscape.
The Regulatory and Ethical Frontier
As AI-powered biological engineering advances, the need for oversight becomes increasingly urgent. Woolfson acknowledges the disruptive potential of creating new life and calls for principles to ensure “artificial biological intelligence” delivers benefits equitably while preserving natural diversity and human free will. Yet he offers few concrete prescriptions for building the formidable safeguards needed in a world of commercial competition and uneven regulation.
This governance gap is particularly concerning given the military applications already emerging. The Pentagon is developing AI-powered cyber tools to identify vulnerabilities in China’s critical infrastructure, with $200 million in contracts awarded to leading AI companies. This has created tensions with companies like Anthropic, which recently rejected a Pentagon ultimatum to allow unrestricted military use of its AI models, citing concerns about mass surveillance and autonomous weapons.
The Human Dimension
Beyond the laboratory and boardroom, AI is reshaping what it means to create and work. New tools like Claude Code and OpenAI Codex enable non-programmers to build functional software through natural language prompts – a development one user described as feeling “like having a little coding alien on my shoulder.” This democratization of software development raises questions about quality control and understanding of underlying systems, with some experts suggesting the need for “vibe-coding licenses” for public software.
Meanwhile, a new professional role is emerging to manage AI’s growing influence: the AI auditor. Similar to financial auditors but focused on AI systems, these professionals monitor model behavior for bias, hallucinations, and unauthorized actions. Zohar Bronfman, CEO of Pecan.ai, notes that while current oversight resembles quality assurance, true AI auditing will require multidisciplinary teams combining technical expertise with knowledge of law, ethics, and behavioral science.
Balancing Promise and Precaution
The convergence of AI and biology represents one of humanity’s most profound technological leaps – a chance to move from observing evolution to directing it. Yet this power comes with unprecedented responsibility. As we stand at the threshold of becoming “authors of species,” we must confront fundamental questions about control, equity, and what it means to be human in an age of artificial biological intelligence.
The path forward requires more than technological innovation. It demands robust governance frameworks, transparent oversight mechanisms, and ongoing public dialogue about the ethical boundaries of life creation. As Woolfson’s work suggests, the future of species may depend less on what we can create than on the wisdom we bring to the creation process.